Table 1.
Demographic and clinical features of CL and ML cured individuals
| Cutaneous leishmaniasis (n = 20) | Mucosal leishmaniasis (n = 20) | |
|---|---|---|
|
Age |
23 (13–48) |
37 (12–58) |
|
Gender (male) |
13 (65%) |
15 (75%) |
|
Skin test area (mm
2
) |
187 (80–625) |
300 (56–1722) |
|
Series of pentavalent antimony |
|
|
| 1 |
17 (85%) |
10 (50%) |
| 2 |
3 (15%) |
9 (45%) |
| 3 |
- |
1 (5%) |
|
Stage of mucosal disease |
|
|
| II |
- |
8 (40%) |
| III |
- |
8 (40%) |
| ≥ IV |
- |
4 (20%) |
| Months between evaluations | 94 (38–161) | 106 (28–184) |